Tag: Immune checkpoint inhibitors

Dec282024 by adminNo Comments

AI Model Has Promise for Predicting Checkpoint Inhibitor Activity in NSCLC

Oncology/Hematology > > Lung Cancer-- Score based upon pathology images an independent predictor of PFS, OS by Charles Bankhead, Senior Editor, MedPage Today December 27, 2024 Expert system (AI)-assisted analysis of pathology slides revealed prospective as a predictive biomarker for non-small cell lung cancer (NSCLC) action to immune checkpoint inhibitors (ICIs), a multicenter research study revealed. The deep-learning design (called Deep-IO) accomplished a location under the receiver operating particular curve (AUC) of 0.75 for unbiased reaction in a U.S.-based developmental associate and 0.66 in a Europe-...

Dec142024 by adminNo Comments

Generic platinum chemotherapy lacks did not increase deaths

Science and Nature

Throughout a lack of the generic platinum chemotherapy drugs cisplatin and carboplatin that started in early 2023, there was no distinction in death rates amongst clients with innovative cancer compared to the previous year, and prescription rates for the 2 drugs fell less than 3 percent in general-- and 15.1 percent at the peak-- according to an analysis released today in the Journal of the National Cancer Institute By scientists from the University of Pennsylvania's Perelman School of Medicine and Penn Medicine's Abramson Cancer. Cisplatin and carboplatin-- which have actually been authorized for more than 30 years-- are extensively utilized to deal with a range of cancers, consisting of lung, head and neck, breast, bladder, ovarian, uterine, and testicular cancers. When the FDA revealed...